Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Non-cash Items (2016 - 2020)

Historic Non-cash Items for United Therapeutics (UTHR) over the last 10 years, with Q1 2020 value amounting to $5.2 million.

  • United Therapeutics' Non-cash Items fell 9636.05% to $5.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.2 million, marking a year-over-year decrease of 9636.05%. This contributed to the annual value of $3.9 million for FY2019, which is 9500.2% down from last year.
  • According to the latest figures from Q1 2020, United Therapeutics' Non-cash Items is $5.2 million, which was down 9636.05% from $3.9 million recorded in Q4 2019.
  • In the past 5 years, United Therapeutics' Non-cash Items ranged from a high of $176.7 million in Q4 2016 and a low of $3.1 million during Q3 2017
  • Moreover, its 5-year median value for Non-cash Items was $48.0 million (2016), whereas its average is $65.1 million.
  • Per our database at Business Quant, United Therapeutics' Non-cash Items soared by 375504.64% in 2018 and then plummeted by 9636.05% in 2020.
  • Over the past 5 years, United Therapeutics' Non-cash Items (Quarter) stood at $176.7 million in 2016, then dropped by 3.11% to $171.2 million in 2017, then crashed by 54.09% to $78.6 million in 2018, then plummeted by 95.0% to $3.9 million in 2019, then soared by 32.86% to $5.2 million in 2020.
  • Its Non-cash Items stands at $5.2 million for Q1 2020, versus $3.9 million for Q4 2019 and $108.4 million for Q3 2019.